Emletra Tablet 1's belongs to a class of drugs called antiretrovirals used in the treatment of HIV infection. Emletra Tablet 1's helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome). Emletra Tablet 1's may be used in combination with other antiviral drugs. HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system and destroys the white blood cells that help in fighting infection, making the individual susceptible to other infections or illnesses.

Emletra Tablet 1's is a combination of two antiretroviral drugs, namely: Lopinavir and Ritonavir. Lopinavir works by inhibiting the working of a protease enzyme that is essential for the reproduction of HIV. Thereby, it prevents the production of the new virus. Ritonavir slows the breakdown of Lopinavir by the liver and increases the levels of Lopinavir in the blood and making it effective against the virus. Together, they help to control HIV infection.

Take Emletra Tablet 1's as prescribed by your doctor. You are advised to take Emletra Tablet 1's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience nausea, vomiting, diarrhea, upper respiratory tract infection, indigestion, decreased appetite, headache, or dizziness. Most of these side effects of Emletra Tablet 1's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Emletra Tablet 1's or any other medicines, please tell your doctor. Emletra Tablet 1's is not recommended for children below 2 years of age as the safety and effectiveness were not established. If you are pregnant, planning for pregnancy, or breastfeeding, please consult a doctor before taking Emletra Tablet 1's. You are recommended to avoid the consumption of alcohol with Emletra Tablet 1's as it may increase the risk of liver damage. Drive only if you are alert as Emletra Tablet 1's may cause dizziness.

Emletra Tablet 1's contains Lopinavir and Ritonavir used in the treatment of HIV infection. Emletra Tablet 1's may be used in combination with other antiviral drugs. Lopinavir inhibits the working of the protease enzyme that is essential for the reproduction of HIV. Thereby, it prevents the production of the new virus. Ritonavir slows the breakdown of Lopinavir by the liver and increases the levels of Lopinavir in the blood and making it effective against the virus. Together, they help to control HIV infection by slowing the spread of infection in the body. Taking Emletra Tablet 1's along with practicing safe sex and lifestyle changes may reduce the risk of getting or transmitting HIV to others.

If you are allergic to Emletra Tablet 1's or any other medicines, please tell your doctor. Emletra Tablet 1's is not recommended for children below 2 years of age as the safety and effectiveness were not established. If you are pregnant or planning for pregnancy, please consult a doctor before taking Emletra Tablet 1's. HIV-infected women are recommended to avoid breastfeeding as the baby may be infected through breast milk. Please consult a doctor if you are breastfeeding before taking Emletra Tablet 1's. You are recommended to avoid consumption of alcohol with Emletra Tablet 1's as it may increase the risk of liver damage. Drive only if you are alert as Emletra Tablet 1's may cause dizziness. You are advised to take proper precautions if you are infected with HIV infection to prevent the spread of infection to others through sexual contact or body fluids. If you experience stomach pain, difficulty in breathing, vomiting, nausea and severe weakness in the muscles of arms and legs, please consult a doctor immediately as these might be symptoms of increased lactic acid levels.

Certain tests are recommended while taking Emletra Tablet 1's to monitor the changes in levels of blood lipids and glucose.